AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Owens & Minor Reports 3rd Quarter 2019 Financial Results

November 6, 2019

RICHMOND, Va.--(BUSINESS WIRE)--Nov 6, 2019--

Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the third quarter ended September 30, 2019, as summarized in the table below.

“I am excited to announce that we had another quarter with significant sequential improvement. Our third quarter results show back-to-back quarters of sequential growth in operating income and EPS, expansion of quarterly operating cash flow, additional reduction in working capital and an increased pace of debt pay down. This is a result of our teammates actively embracing our focus around serving our customers and driving productivity,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.

“Additionally, we have improved our service metrics to levels that have not been achieved in years. The strong performance and consistency of our service gives us confidence that many of the past service issues have been resolved, however we will continue to drive additional initiatives to further improve and provide innovative services. We continue to focus on productivity and efficiency initiatives to drive operating improvements in our core businesses: distribution channel, product manufacturing, home healthcare, and acute care services. While we are ahead of the long-term recovery plan I envisioned when I joined in March, we recognize that there is still a significant amount of work ahead. We will not take our customers for granted and will continue to provide a high level of customer focus while maintaining industry- leading integrity.”

  
 

Financial Summary

YTD

YTD

 

($ in millions, except per share data)

3Q19

3Q18

2019

2018

 

 

 

 

 

 
 

Revenue

$2,399

$2,465

$7,345

$7,296

 

 

 

 

 

 
 

Operating income, GAAP 1,2

$25.3

$21.4

$56.2

($126)

 

Adj. Operating income, Non-GAAP 1,2

$42.3

$48.8

$109

$143

 

 

 

 

 

 
 

Net income (loss), GAAP 1,2

$1.2

($0.6)

($23.3)

($175)

 

Adj. Net income, Non-GAAP 1,2

$12.2

$19.5

$19.3

$65.1

 

 

 

 

 

 
 

Net Income (loss) per share, GAAP 1,2

$0.02

($0.01)

($0.39)

($2.92)

 

Adj. Net Income per share, Non-GAAP 1,2

$0.20

$0.32

$0.32

$1.06

 

Adj. Net Income per share, Non-GAAP, constant currency 1,2,3

$0.22

 

$0.32

 

$0.34

 

$1.06

 

 
1.

Reconciliations of the differences between the non-GAAP financial measures presented in this news release and their most directly comparable GAAP financial measures are included in the financial tables below.

2.

Year-to-date comparisons to prior year results are impacted by the second quarter 2018 goodwill and intangible asset impairment charge of $165 million, or $2.73 per share. This charge was classified as a non-GAAP item and, accordingly, did not affect results reported on an adjusted basis.

3.

Adjusted net income per share, non-GAAP at 2018 foreign currency exchange rates.

2019 Results

Highlights

Financial Outlook

For 2019, the Company is adjusting its previously issued guidance range for the timing and amount of anticipated revenue from its early stage value-based care management business (Fusion5) as follows:

 

Adjusted net income per
share range, excluding
foreign currency impact

Narrowed guidance range

$0.60

 

 

$0.65

 

Impact of Fusion5 revenue amount and timing

(0.06

)

 

(0.06

)

 

$0.54

 

$0.59

Excluding the impact of Fusion5 and foreign currency, the company now expects 2019 adjusted net income per share to be in a range of $0.60 to $0.65.

Although the company does provide guidance for adjusted net income per share (which is a non-GAAP financial measure), it is not able to forecast the most directly comparable measure calculated and presented in accordance with GAAP without unreasonable effort. Certain elements of the composition of the GAAP amount are not predictable, making it impracticable for the company to forecast. Such elements include, but are not limited to restructuring and acquisition charges. As a result, no GAAP guidance or reconciliation of the company’s adjusted net income per share guidance is provided. For the same reasons, the company is unable to assess the probable significance of the unavailable information, which could have a potentially significant impact on its future GAAP financial results. The outlook is based on certain assumptions that are subject to the risk factors discussed in the company’s filings with the Securities and Exchange Commission (“SEC”).

Dividend Information

The Board of Directors approved a fourth quarter dividend payment of $0.0025 per share, payable on December 31, 2019, to shareholders of record as of December 16, 2019.

Investor Conference Call for 3Q 2019 Financial Results

Owens & Minor executives will host a conference call, which will also be webcast, to discuss the results at 8:30 a.m. EST on Wednesday, November 6, 2019. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. A replay of the call will be available for one week by dialing 855-859-2056. The access code for the conference call, international dial-in and replay is #2309649. A webcast of the event will be available on www.owens-minor.com under the Investor Relations section.

Safe Harbor

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC’s Fair Disclosure Regulation. This release contains certain ″forward-looking″ statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the statements in this release regarding our expectations with respect to our 2019 financial performance, as well as other statements related to the company’s expectations regarding the performance of its business, growth, and improvement of operational performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to Owens & Minor’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC including the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the company’s actual results to differ materially from its current estimates. These filings are available at www.owens-minor.com. Given these risks and uncertainties, Owens & Minor can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not to place undue reliance on them. Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

Owens & Minor uses its web site, www.owens-minor.com, as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under the Investor Relations section.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a global healthcare solutions company with integrated technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. With 17,000 dedicated teammates serving healthcare industry customers in 90 countries, Owens & Minor helps to reduce total costs across the supply chain by optimizing episode and point-of-care performance, freeing up capital and clinical resources, and managing contracts to optimize financial performance. A FORTUNE 500 company, Owens & Minor was founded in 1882 in Richmond, Virginia, where it remains headquartered today. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter, and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

 

Owens & Minor, Inc.

Consolidated Statements of Income (Loss) (unaudited)

(dollars in thousands, except per share data)
 

 

 

Three Months Ended September 30,

 

 

2019

 

2018

Net revenue

 

$

2,399,017

 

 

$

2,464,877

 

Cost of goods sold

 

2,036,530

 

 

2,112,303

 

Gross margin

 

362,487

 

 

352,574

 

Distribution, selling and administrative expenses

 

332,369

 

 

325,012

 

Acquisition-related and exit and realignment charges

 

4,905

 

 

7,727

 

Other operating income, net

 

(101

)

 

(1,522

)

Operating income

 

25,314

 

 

21,357

 

Interest expense, net

 

25,938

 

 

23,826

 

Other income, net

 

(185

)

 

 

Loss before income taxes

 

(439

)

 

(2,469

)

Income tax benefit

 

(1,663

)

 

(1,904

)

Net income (loss)

 

$

1,224

 

 

$

(565

)

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

Basic and diluted

 

$

0.02

 

 

$

(0.01

)

 

 

Nine Months Ended September 30,

 

 

2019

 

2018

Net revenue

 

$

7,344,605

 

 

$

7,295,727

 

Cost of goods sold

 

6,255,266

 

 

6,293,474

 

Gross margin

 

1,089,339

 

 

1,002,253

 

Distribution, selling and administrative expenses

 

1,016,965

 

 

918,147

 

Goodwill and intangible asset impairment charges

 

 

 

165,447

 

Acquisition-related and exit and realignment charges

 

15,550

 

 

47,416

 

Other operating expense (income), net

 

674

 

 

(2,281

)

Operating income (loss)

 

56,150

 

 

(126,476

)

Interest expense, net

 

80,718

 

 

52,651

 

Other expense, net

 

1,818

 

 

 

Loss before income taxes

 

(26,386

)

 

(179,127

)

Income tax benefit

 

(3,038

)

 

(3,936

)

Net loss

 

$

(23,348

)

 

$

(175,191

)

 

 

 

 

 

Net loss per common share:

 

 

 

 

Basic and diluted

 

$

(0.39

)

 

$

(2.92

)

Owens & Minor, Inc.

Condensed Consolidated Balance Sheets (unaudited)

(dollars in thousands)

 

 

 

September 30, 2019

 

December 31, 2018

 

 

 

 

 

Assets

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

96,803

 

 

$

103,367

 

Accounts receivable, net

 

741,670

 

 

823,418

 

Merchandise inventories

 

1,153,079

 

 

1,290,103

 

Other current assets

 

259,708

 

 

321,690

 

Total current assets

 

2,251,260

 

 

2,538,578

 

Property and equipment, net

 

383,825

 

 

386,723

 

Operating lease assets

 

234,853

 

 

 

Goodwill

 

398,065

 

 

414,122

 

Intangible assets, net

 

299,874

 

 

321,764

 

Other assets, net

 

120,542

 

 

112,601

 

Total assets

 

$

3,688,419

 

 

$

3,773,788

 

Liabilities and equity

 

 

 

 

Current liabilities

 

 

 

 

Accounts payable

 

$

873,743

 

 

$

1,109,589

 

Accrued payroll and related liabilities

 

62,081

 

 

48,203

 

Other current liabilities

 

359,965

 

 

314,219

 

Total current liabilities

 

1,295,789

 

 

1,472,011

 

Long-term debt, excluding current portion

 

1,553,991

 

 

1,650,582

 

Operating lease liabilities, excluding current portion

 

198,858

 

 

 

Deferred income taxes

 

50,553

 

 

50,852

 

Other liabilities

 

97,950

 

 

81,924

 

Total liabilities

 

3,197,141

 

 

3,255,369

 

Total equity

 

491,278

 

 

518,419

 

Total liabilities and equity

 

$

3,688,419

 

 

$

3,773,788

 

Owens & Minor, Inc.

Consolidated Statements of Cash Flows (unaudited)
(dollars in thousands)
 

 

 

Nine Months Ended September 30,

 

 

2019

 

2018

 

 

 

 

 

Operating activities:

 

 

 

 

Net loss

 

$

(23,348

)

 

$

(175,191

)

Adjustments to reconcile net loss to cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

88,204

 

 

73,596

 

Share-based compensation expense

 

12,057

 

 

10,499

 

Goodwill and intangible asset impairment charges

 

 

 

165,447

 

Provision for losses on accounts receivable

 

9,759

 

 

5,757

 

Deferred income tax benefit

 

(11,989

)

 

(6,754

)

Changes in operating lease right-of-use assets and lease liabilities

 

(1,280

)

 

 

Changes in operating assets and liabilities:

 

 

 

 

Accounts receivable

 

73,986

 

 

(51,603

)

Merchandise inventories

 

136,021

 

 

21,244

 

Accounts payable

 

(221,381

)

 

88,198

 

Net change in other assets and liabilities

 

69,756

 

 

(11,522

)

Other, net

 

7,320

 

 

2,838

 

Cash provided by operating activities

 

139,105

 

 

122,509

 

 

 

 

 

 

Investing activities:

 

 

 

 

Acquisitions, net of cash acquired

 

 

 

(751,834

)

Additions to property and equipment

 

(31,224

)

 

(32,489

)

Additions to computer software

 

(6,928

)

 

(14,816

)

Proceeds from sale of property and equipment

 

220

 

 

258

 

Cash used for investing activities

 

(37,932

)

 

(798,881

)

 

 

 

 

 

Financing activities:

 

 

 

 

Proceeds from issuance of debt

 

 

 

695,750

 

(Repayments) borrowings under revolving credit facility

 

(36,100

)

 

74,762

 

Repayments of debt

 

(40,700

)

 

(9,375

)

Financing costs paid

 

(4,313

)

 

(28,512

)

Cash dividends paid

 

(5,072

)

 

(32,151

)

Other, net

 

(3,109

)

 

(5,308

)

Cash (used for) provided by financing activities

 

(89,294

)

 

695,166

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

(2,243

)

 

1,574

 

 

 

 

 

 

Net increase in cash, cash equivalents and restricted cash

 

9,636

 

 

20,368

 

Cash, cash equivalents and restricted cash at beginning of period

 

103,367

 

 

104,522

 

Cash, cash equivalents and restricted cash at end of period (1)

 

$

113,003

 

 

$

124,890

 

 

(1) Restricted cash represents $16.2 million held in an escrow account as of September 30, 2019 as required by the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Bundled Payments for Care Improvement (BPCI) Advanced Program.

Owens & Minor, Inc.

Summary Segment Information (unaudited)
(dollars in thousands)
 

 

Three Months Ended September 30,

 

2019

 

2018

 

 

 

% of

 

 

 

% of

 

 

 

consolidated

 

 

 

consolidated

 

Amount

 

net revenue

 

Amount

 

net revenue

Net revenue:

 

 

 

 

 

 

 

Segment net revenue

 

 

 

 

 

 

 

Global Solutions

$

2,153,644

 

 

89.77

%

 

$

2,243,782

 

 

91.03

%

Global Products

359,835

 

 

15.00

%

 

349,895

 

 

14.20

%

Total segment net revenue

2,513,479

 

 

 

 

2,593,677

 

 

 

Inter-segment revenue

 

 

 

 

 

 

 

Global Products

(114,462

)

 

(4.77

)%

 

(128,800

)

 

(5.23

)%

Total inter-segment revenue

(114,462

)

 

 

 

(128,800

)

 

 

Consolidated net revenue

$

2,399,017

 

 

100.00

%

 

$

2,464,877

 

 

100.00

%

 

 

 

 

 

 

 

 

 

 

 

% of segment

 

 

 

% of segment

Operating income:

 

 

net revenue

 

 

 

net revenue

Global Solutions

$

25,626

 

 

1.19

%

 

$

24,150

 

 

1.08

%

Global Products

16,897

 

 

4.70

%

 

27,634

 

 

7.90

%

Inter-segment eliminations

(242

)

 

 

 

(2,957

)

 

 

Intangible amortization

(10,949

)

 

 

 

(10,366

)

 

 

Acquisition-related and exit and realignment charges

(4,905

)

 

 

 

(7,727

)

 

 

Other (1)

(1,113

)

 

 

 

(9,377

)

 

 

Consolidated operating income

$

25,314

 

 

1.06

%

 

$

21,357

 

 

0.87

%

 

 

 

 

 

 

 

 

Depreciation and amortization:

 

 

 

 

 

 

 

Global Solutions

$

16,174

 

 

 

 

$

15,829

 

 

 

Global Products

13,128

 

 

 

 

13,953

 

 

 

Consolidated depreciation and amortization

$

29,302

 

 

 

 

$

29,782

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures:

 

 

 

 

 

 

 

Global Solutions

$

5,830

 

 

 

 

$

12,006

 

 

 

Global Products

6,791

 

 

 

 

5,245

 

 

 

Consolidated capital expenditures

$

12,621

 

 

 

 

$

17,251

 

 

 

Owens & Minor, Inc.
Summary Segment Information (unaudited), continued

(dollars in thousands)

 

Nine Months Ended September 30,

 

2019

 

2018

 

 

 

% of

 

 

 

% of

 

 

 

consolidated

 

 

 

consolidated

 

Amount

 

net revenue

 

Amount

 

net revenue

Net revenue:

 

 

 

 

 

 

 

Segment net revenue

 

 

 

 

 

 

 

Global Solutions

$

6,629,756

 

 

90.27

%

 

$

6,875,077

 

 

94.23

%

Global Products

1,070,808

 

 

14.58

%

 

750,770

 

 

10.29

%

Total segment net revenue

7,700,564

 

 

 

 

7,625,847

 

 

 

Inter-segment revenue

 

 

 

 

 

 

 

Global Products

(355,959

)

 

(4.85

)%

 

(330,120

)

 

(4.52

)%

Total inter-segment revenue

(355,959

)

 

 

 

(330,120

)

 

 

Consolidated net revenue

$

7,344,605

 

 

100.00

%

 

$

7,295,727

 

 

100.00

%

 

 

 

 

 

 

 

 

 

 

 

% of segment

 

 

 

% of segment

Operating income (loss):

 

 

net revenue

 

 

 

net revenue

Global Solutions

$

66,152

 

 

1.00

%

 

$

84,742

 

 

1.23

%

Global Products

42,570

 

 

3.98

%

 

61,351

 

 

8.17

%

Inter-segment eliminations

774

 

 

 

 

(3,032

)

 

 

Goodwill and intangible asset impairment charges

 

 

 

 

(165,447

)

 

 

Intangible amortization

(34,415

)

 

 

 

(26,147

)

 

 

Acquisition-related and exit and realignment charges

(15,550

)

 

 

 

(47,416

)

 

 

Other (1)

(3,381

)

 

 

 

(30,527

)

 

 

Consolidated operating income (loss)

$

56,150

 

 

0.76

%

 

$

(126,476

)

 

(1.73

)%

 

 

 

 

 

 

 

 

Depreciation and amortization:

 

 

 

 

 

 

 

Global Solutions

$

47,222

 

 

 

 

$

47,464

 

 

 

Global Products

40,982

 

 

 

 

26,132

 

 

 

Consolidated depreciation and amortization

$

88,204

 

 

 

 

$

73,596

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures:

 

 

 

 

 

 

 

Global Solutions

$

24,578

 

 

 

 

$

40,152

 

 

 

Global Products

13,574

 

 

 

 

7,153

 

 

 

Consolidated capital expenditures

$

38,152

 

 

 

 

$

47,305

 

 

 

 

(1) Other consists of Software as a Service (SaaS) implementation costs associated with significant global IT platforms in connection with the redesign of our global information system strategy and an incremental charge in the prior year periods to cost of goods sold from purchase accounting impacts related to the sale of acquired inventory that was written up to fair value.

Owens & Minor, Inc.
Net Income (Loss) Per Common Share (unaudited)
(dollars in thousands, except per share data)
 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2019

 

2018

 

2019

 

2018

Numerator:

 

 

 

 

 

 

 

Net income (loss) attributable to common shareholders - basic and diluted

$

1,224

 

 

$

(565

)

 

$

(23,348

)

 

$

(175,191

)

Denominator:

 

 

 

 

 

 

 

Weighted average shares outstanding - basic and diluted

60,030

 

 

59,766

 

 

60,498

 

 

59,996

 

Net income (loss) per share attributable to common shareholders:

 

 

 

 

 

 

 

Basic and diluted

$

0.02

 

 

$

(0.01

)

 

$

(0.39

)

 

$

(2.92

)

Owens & Minor, Inc.
GAAP/Non-GAAP Reconciliations (unaudited)
 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

(Dollars in thousands except per share data)

2019

 

2018

 

2019

 

2018

Operating income (loss), as reported (GAAP)

$

25,314

 

 

$

21,357

 

 

$

56,150

 

 

$

(126,476

)

Intangible amortization (1)

10,949

 

 

10,366

 

 

34,415

 

 

26,147

 

Goodwill and intangible asset impairment charges (4)

 

 

 

 

 

 

165,447

 

Acquisition-related and exit and realignment charges (2)

4,905

 

 

7,727

 

 

15,550

 

 

47,416

 

Fair value adjustments related to purchase accounting (5)

 

 

9,029

 

 

 

 

27,088

 

Other (3)

1,113

 

 

348

 

 

3,381

 

 

3,439

 

Operating income, adjusted (non-GAAP) (Adjusted Operated Income)

$

42,281

 

 

$

48,827

 

 

$

109,496

 

 

$

143,061

 

Operating income (loss) as a percent of revenue (GAAP)

1.06

%

 

0.87

%

 

0.76

%

 

(1.73

)%

Adjusted operating income as a percent of revenue (non-GAAP)

1.76

%

 

1.98

%

 

1.49

%

 

1.96

%

 

 

 

 

 

 

 

 

Net income (loss), as reported (GAAP)

$

1,224

 

 

$

(565

)

 

$

(23,348

)

 

$

(175,191

)

Intangible amortization (1)

10,949

 

 

10,366

 

 

34,415

 

 

26,147

 

Income tax expense (benefit) (7)

(3,898

)

 

(2,209

)

 

(8,167

)

 

(6,284

)

Goodwill and intangible asset impairment charges (4)

 

 

 

 

 

 

165,447

 

Income tax expense (benefit) (7)

 

 

 

 

 

 

(2,060

)

Acquisition-related and exit and realignment charges (2)

4,905

 

 

7,727

 

 

15,550

 

 

47,416

 

Income tax expense (benefit) (7)

(1,639

)

 

(1,575

)

 

(3,394

)

 

(11,843

)

Fair value adjustments related to purchase accounting (5)

 

 

9,029

 

 

 

 

27,088

 

Income tax expense (benefit) (7)

 

 

(1,922

)

 

 

 

(6,872

)

Other (3)

928

 

 

348

 

 

5,199

 

 

3,439

 

Income tax expense (benefit) (7)

(317

)

 

(85

)

 

(967

)

 

(558

)

Tax adjustments (6)

 

 

(1,596

)

 

 

 

(1,596

)

Net income, adjusted (non-GAAP) (Adjusted Net Income)

$

12,152

 

 

$

19,518

 

 

$

19,288

 

 

$

65,133

 

 

 

 

 

 

 

 

 

Net income (loss) per diluted common share, as reported (GAAP)

$

0.02

 

 

$

(0.01

)

 

$

(0.39

)

 

$

(2.92

)

Intangible amortization (1)

0.12

 

 

0.14

 

 

0.44

 

 

0.32

 

Goodwill and intangible asset impairment charges (4)

 

 

 

 

 

 

2.73

 

Acquisition-related and exit and realignment charges (2)

0.05

 

 

0.10

 

 

0.20

 

 

0.58

 

Fair value adjustments related to purchase accounting (5)

 

 

0.11

 

 

 

 

0.33

 

Other (3)

0.01

 

 

 

 

0.07

 

 

0.04

 

Tax adjustments (6)

 

 

(0.02

)

 

 

 

(0.02

)

Net income per diluted common share, adjusted (non-GAAP) (Adjusted EPS)

$

0.20

 

 

$

0.32

 

 

$

0.32

 

 

$

1.06

 

Impact of currency at 2018 foreign currency exchange rates

0.02

 

 

 

 

0.02

 

 

 

Net income per diluted common share, on a constant currency basis (8)

$

0.22

 

 

$

0.32

 

 

$

0.34

 

 

$

1.06

 

Owens & Minor, Inc.

GAAP/Non-GAAP Reconciliations (unaudited), continued

The following items have been excluded in our non-GAAP financial measures:

(1) Intangible amortization includes amortization of intangible assets established during purchase accounting for business combinations. These amounts are highly dependent on the size and frequency of acquisitions and are being excluded to allow for a more consistent comparison with forecasted, current and historical results and the results of our peers.

(2) Acquisition-related charges were $3.6 million and $11.4 million for the three and nine months ended September 30, 2019, compared to $5.7 million and $41.0 million for the same period of 2018. Acquisition-related charges in 2019 and 2018 consist primarily of transition and transaction costs for the Halyard transaction.

Exit and realignment charges were $1.4 million and $4.2 million for the three and nine months ended September 30, 2019. Amounts in 2019 were associated with severance costs, the establishment of our client engagement centers, and IT restructuring charges. Exit and realignment charges were $2.0 million and $6.4 million for the three and nine months ended September 30, 2018. Amounts in 2018 were associated with the establishment of our client engagement centers.

(3) Other consists of Software as a Service (SaaS) implementation costs associated with significant global IT platforms in connection with the redesign of our global information system strategy of $1.1 million and $3.4 million for the three and nine months ended September 30, 2019.

Other also consists of the write-off of deferred financing costs associated with the revolving credit facility as a result of the Fourth Amendment to the Credit Agreement in February 2019 of $2.0 million and gain on extinguishment of debt related to the partial repurchase of our 2021 Notes in September 2019 of $0.2 million.

(4) Goodwill and intangible assets impairment charges in 2018 included in our Global Products segment were $149 million and $16.5 million, respectively.

(5) The second and third quarters of 2018 include an incremental charge to cost of goods sold from purchase accounting impacts related to the sale of acquired inventory that was written up to fair value in connection with the Halyard acquisition.

(6) Includes tax adjustments primarily associated with the estimated benefits under the Tax Cuts and Jobs Act.

(7) These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes.

(8) Excludes the impact of translational currency, which assumes 2019 results at 2018 rates.

Use of Non-GAAP Measures

This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.’s (the “Company”) core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company’s performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company’s performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by the Company should not be considered substitutes for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191106005490/en/

Chuck Graves, Director, Finance & Investor Relations, 804-723-7556,Chuck.Graves@owens-minor.com

KEYWORD: VIRGINIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH TECHNOLOGY SOFTWARE MEDICAL SUPPLIES

SOURCE: Owens & Minor

Copyright Business Wire 2019.

PUB: 11/06/2019 06:52 AM/DISC: 11/06/2019 06:52 AM

http://www.businesswire.com/news/home/20191106005490/en